HCPCS code J2281 — Inj moxifloxacin (fres kabi). Status: Active. Effective Jul 1, 2024. Source: CMS HCPCS Level II.

J2281

Active

Inj moxifloxacin (fres kabi)

Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2024
Code type: alphanumeric
OPPS Status: N — Items / services packaged into APC rates

MUE — Medically Unlikely Edits

Maximum units of J2281 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 4
Outpatient Hospital 4
Practitioner Services 4

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
63323-0850-74 Moxifloxacin HCl

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q3
    Inj moxifloxacin (fres kabi)